From the Archives: Mother-daughter mechanic team Omaha's Auto Tuning Center

From the Archives: Mother-daughter mechanic team Omaha's Auto Tuning Center
Margo Geisler, left, assists her daughter Debi, 22, at tuning an engine at the Auto Tuning Center in Omaha. Margo is the president of the two-location service center and Debi is the vice-president. According to an April 1976 World-Herald article, some …
Read more on Omaha World-Herald (blog)

auto mechanic and Teacher Scott Tucker Receives Teaching Award
Simply Awesome Cars shares an in-depth interview with Scott Tucker, the latest recipient of the Tipman teaching award. Nashville, TN — (ReleaseWire) — 03/02/2015 — Simply Awesome Cars, a web portal for car enthusiasts, is featuring Scott Tucker in …
Read more on Digital Journal

Latest Automotive Repair News

The Buzz: New store, great beer and new location
The family-owned and operated auto repair shop has moved from its former First Avenue South location to 800 1st Ave. N. Owners Bud and Deb Hudson completed the move March 1. They made extensive renovations at the new location, which gives them …
Read more on Great Falls Tribune

Automotive Industry Veteran Steve Moretti Joins RepairPal as VP & GM
RepairPal, the leading resource for consumer auto repair, announces Steve Moretti has joined the company as Vice President & General Manager, Business Development. Moretti will oversee all new business development and strengthen relationships with …
Read more on PR Web (press release)

Car repair started Burlington house fire
Burlington House Fire Ignited by Auto Repair Work. Deputy State Fire Marshal Peter J. Ostroskey and Burlington Fire Chief Steve M. Yetman said the March 21, 2015 house fire at 4 Marion Road, Burlington was accidental. It started in the attached garage …
Read more on Wicked Local Burlington

Latest Mechanic News

Job Openings: Small Engine Mechanic, Bookkeeper, Office Staff & More In This
Small Engine Mechanic: ASJ Small Engines, Etc. is looking for a Small Engine Mechanic. Experience is preferred but not required. Repair on all types of outdoor power equipment. This is an hourly position. $ 12-$ 13 per hour depending on experience. May …
Read more on Carson Valley Times

Mechanic takes an IOU from a stranger
My heartful thanks to AD Enterprise on Dewey Avenue. My car was not handling right over the weekend, but I knew I would not have money for repairs until payday on Thursday. I went in on Monday to ask Tony if he thought it was safe to drive until Thursday.
Read more on Rochester Democrat and Chronicle

Does System Mechanic Speed Up Your Computer?
The same could be said when KnowTechie had the chance to check out System Mechanic's latest update from iolo. I was not expecting much from it, but after using System Mechanic, however, I can happily report that it actually does work and is a breeze to …
Read more on KnowTechie

Assets of Iconic Lund Cadillac to Hit the Auction Block This Week

Phoenix, AZ (PRWEB) February 24, 2015

After almost 25 years as a fixture on Bell Rd and 13th St. in Phoenix, Lund Cadillac has closed its doors for good. Now, the remaining assets are being offered to the general public through a strategic partnership Auction Nation, whos headquarters is in Phoenix.

Very rarely does the general public get an opportunity to bid on and own a piece of a company that was so well known and respected says Gabriel Prado, Founder and President of Auction Nation. This is an amazing opportunity not only for people in the auto dealer and auto mechanic industries, but for auto enthusiasts and the general public alike to bid on and purchase the assets from the Lund Cadillac dealership.

The dealership rights and inventory are now part of the brand new state of the art Arrowhead Cadillac on Bell and 83rd Ave. Taking only the vehicle inventory, all remaining assets of Lund Cadillac will be auctioned off in a 5 part, 5 week online auction through the website http://www.AuctionNation.net

I have been in the car business for many years and I have never seen an opportunity like this says Roger Waller, local car dealer. To be able to bid on such high quality automotive equipment at no reserve is truly unbelievable.

Assets at the Bell Rd. and 13th St. dealership location include dozens of vehicle lifts, tire machines, storage containers, car washes, office furniture, TVs and even fixtures on the building. All bidding will take place on the AuctionNation.net website and will be held every Wednesday for the next 5 weeks. Registration is free and good for all 5 auctions. There will be an open house preview done each Wednesday from 10am to 4pm to see the assets in person prior to bidding. For full details and a complete schedule of all five Lund Cadillac liquidation Auctions visit http://www.AuctionNation.net.

Auction Nation is a nationwide online auction company specializing in commercial business liquidations and relocations. Auction Nation currently has offices in: Phoenix, Tucson, Albuquerque, Milwaukee, Portland, Pensacola, Las Vegas, Dallas, Denver and Seattle. They have quickly become one of the fastest growing privately held auction companies in the nation!







More Auto Mechanic Press Releases

Global Explosives & Narcotics Trace Detection Market to Grow by 14% Between 2015 and 2020, Says a New Report by Homeland Security Research Corp.


Washington D.C. (PRWEB) February 24, 2015

Explosives and Narcotics Trace Detection (ETD) is a key modality within the Homeland Security, military and public safety infrastructure. Uses of ETD include air-sea-land transportation security, force protection, law enforcement, critical infrastructure protection and public safety. According to Homeland Security Research Corp.’s (HSRC) latest report, Explosives & Narcotics Trace Detection (ETD): Technologies & Global Market 2015-2020, the ETD market (including systems sales, service, consumables and upgrades) will present multibillion-dollar business opportunities growing at a CAGR of 14% from 2015 to 2020.

The ETD market’s accelerated growth period is driven by:

The January 2015 Paris terror attack leading to a European security funding hike
No competitive explosives and narcotics trace detection products on the horizon
Oil-gas industry security needs
Chinas massive investments in new airports and public security
Middle Eastern terror
Latin America war on drugs
The Indian government counter terror investments
The U.S. and the EU legislations enforcing 100% cargo screening on all passenger flights

The Explosives & Narcotics Trace Detection (ETD): Technologies & Global Market 2015-2020 report segmented into 45 submarkets, offers for each submarket 2011-2014 data, as well as 2015-2020 forecast and analysis. In 538 pages, 157 tables and 137 figures, the report analyzes and projects the market and technologies from several perspectives, including:

Vertical submarkets (e.g., transportation security, secured facilities security)
National and regional markets (U.S., Europe, China, Asia-Pacific, Middle East, Latin America, ROW)
27 national markets data including: national ETD market background, aviation security and more
Over 1700 airports, segmented by country, with their recent traffic data
ETD sales vs. upgrade, consumables and service revenues
Sales by product configuration (hand-held, table-top and other detectors)
Product comparison tables
Major ETD vendors profiles, products and prices including: Auto Clear US (Formerly Control Screening LLC), Biosensor Applications AB, DetectaChem, LLC, Electronic Sensor Technology, Hitachi, Ltd, ICx Technologies (Flir), Ion Applications, Inc., Ketech Defence, Mistral Security, Inc, Morpho Detection Inc., NUCTECH Co. Ltd, Red X Defense, SCANNA MSC Ltd., Scent Detection Technologies, Scintrex Trace, Sibel Ltd, Smiths Detection, Syagen Technology, Thermo Fisher Scientific Inc., Westminster International Ltd.
Market analysis (e.g., market dynamics, market drivers and inhibitors)
Recent U.S. government contracts with ETD suppliers (including general terms & conditions, price lists and more): Control Screening LLC, Federal Resources Supply Co., ICx Technologies Inc., Implant Sciences Corp, Laurus Systems Inc., Morpho Detection, Security 20/20 Inc., Security Detection, Smiths Detection, Treasure Electronics, Inc., Veteran Corps of America, Winvale Group.
Contact info of more than 550 potential ETD customers (authorized air-cargo screening facilities)
Current and pipeline ETD technologies including: Ion Mobility Spectroscopy (IMS), ChemiLuminescence (Thermal Energy Analyzers), Electron Capture Detectors (ECD), Surface Acoustic Wave (SAW), Nanotechnology-enabled Technologies for Explosives Detection, Advanced Sample Collection, Dual Sensor ETD Technology, Chemical Warfare and Narcotics Trace Detectors, Receptor-based Technologies, Molecularly Imprinted Polymers, Nano-mechanical Sensors, Electronic Nose, Silica Micro-cantilever, Surface Enhanced Raman Scattering, Protein Coated Carbon Nanotubes, Piezo-resistive Polymer Cantilever, Inkjet Based Wireless ETD Sensor, Amino-silane Coated Nanowires Arrays, Free-surface Microfluidic Control of Surface-Enhanced Raman Spectroscopy, Molecularly Imprinted Polymers, Cantilever Nano Mechanical Sensors, Sensor Array and Neural Network, Temperature-Stepped Desorption, UV-PLF, Non-Contact Explosives Harvesting, Pulsed-Ultraviolet Laser Raman Spectroscopy, Nanowire-Nano-cluster Hybrids, Laser-Induced Breakdown Spectroscopy (LIBS), MEMS-Based Explosive Particle Detection, Remote Particle Stimulation, Laser Vaporization.
Business opportunities
Product price lists, including list prices and U.S. government prices of 100s systems and consumables
Competitive analysis & SWOT analysis

Explore more Homeland Security and Public Safety Reports at http://www.homelandsecurityresearch.com.

About Homeland Security Research Corp. (HSRC)

HSRC is Homeland Security Research Corp. (HSRC) is an international market research firm specializing in the Homeland Security and Public Safety (HLS & PS) Industry. With an over 750 loyal customer base (72% repeat customers), including dozens of government clients (e.g. U.S Congress, the DHS, U.S Army, U.S Navy, NATO, HLS & Public Safety government agencies in: U.K, Israel, Russia Japan, Korea, China, Canada, Germany, Australia, Sweden, Finland) and over 12 years of mainstream media interviews and citations (e.g. NY Times, CNN, CNBC, Bloomberg), we earned the industry reputation as the gold standard for HLS & PS market and technology reports. Our market and technology research reports enable our clients to gain time critical, industry intelligence by providing them with unique insights, business opportunities, granulated market analysis and in depth current and pipeline technological analysis in each of the submarkets we cover







Cytokinetics Announces Completion of Enrollment in COSMIC-HF

South San Francisco, CA (PRWEB) March 13, 2015

Results Expected Later This Year to Inform Potential Progression of Omecamtiv Mecarbil to Phase III

Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure) has completed enrollment of the approximately 450 patients planned in the expansion phase of the clinical trial. In addition, the company announced that over 200 patients have completed the protocol-specified 20-week duration of dosing in this phase of the trial and reaffirmed that results from COSMIC-HF are expected to be available in the second half of 2015. COSMIC-HF is being conducted by Amgen in collaboration with Cytokinetics.

We are pleased to reach this milestone in the development program for omecamtiv mecarbil, stated Fady I. Malik, M.D., Ph.D., Cytokinetics’ Senior Vice President, Research and Development. COSMIC-HF will provide important information that will inform the potential progression of omecamtiv mecarbil to Phase III. We look forward to data from COSMIC-HF later this year and continue to prepare with Amgen for the initiation of a potential Phase III registration program.

Omecamtiv mecarbil is the companys lead drug candidate from its cardiac muscle contractility program. Amgen holds an exclusive, worldwide license to omecamtiv mecarbil and related compounds, subject to Cytokinetics’ specified development and commercialization rights. Additional information on COSMIC-HF and other completed Phase II clinical trials of omecamtiv mecarbil can be found at http://www.clinicaltrials.gov.

COSMIC-HF: Phase II Clinical Trial of Oral Omecamtiv Mecarbil in Patients with Heart Failure

COSMIC-HF is a double-blind, randomized, placebo-controlled, multicenter, study with two parts, a dose escalation phase and an expansion phase. The dose escalation phase assessed the pharmacokinetics and tolerability of three oral modified-release formulations of omecamtiv mecarbil in patients with heart failure and left ventricular systolic dysfunction and was used to select one formulation for further evaluation. During the dose escalation phase approximately 40 patients were randomized1:1:1:1 to placebo or one of three different oral formulations of omecamtiv mecarbil in each of two ascending dose escalation cohorts. The dose of omecamtiv mecarbil was 25 mg twice daily in the first escalation cohort and 50 mg twice daily in the second escalation cohort. The dose escalation phase of COSMIC-HF completed in 2013 and informed progression to the expansion phase.

The ongoing expansion phase of the trial has enrolled approximately 450 patients randomized 1:1:1 to receive placebo, 25 mg, or 50 mg twice daily of omecamtiv mecarbil. Escalation to the 50 mg dose depends on the plasma concentration of omecamtiv mecarbil following 2 weeks of dosing with 25 mg twice daily. The primary objective of the expansion phase of COSMIC-HF is to characterize the safety, tolerability, and pharmacokinetics of oral omecamtiv mecarbil during 20 weeks of treatment. Secondary objectives are to assess changes from baseline in systolic ejection time, stroke volume, left ventricular end-systolic diameter, left ventricular end-diastolic diameter, heart rate and N-terminal pro-brain natriuretic peptide (a biomarker associated with the severity of heart failure) during 20 weeks of treatment.

About Omecamtiv Mecarbil

Omecamtiv mecarbil is a novel cardiac myosin activator and is the subject of a collaboration between Cytokinetics and Amgen. Cardiac myosin is the cytoskeletal motor protein in the cardiac muscle cell that is directly responsible for converting chemical energy into the mechanical force resulting in cardiac contraction. Cardiac contractility is driven by the cardiac sarcomere, a highly ordered cytoskeletal structure composed of cardiac myosin, actin and a set of regulatory proteins, which is the fundamental unit of muscle contraction in the heart. Cardiac myosin activators have been shown preclinically to work in the absence of changes in intracellular calcium in cardiac myocytes by a novel mechanism that directly stimulates the activity of the cardiac myosin motor protein. Cardiac myosin activators appear to accelerate the rate-limiting step of the myosin enzymatic cycle and shift the enzymatic cycle in favor of the force-producing state. Preclinical research has shown that this mechanism does not increase the velocity of cardiac contraction, but instead, increases the systolic ejection time, resulting in an increase in cardiac contractility and cardiac function in a potentially more oxygen-efficient manner.

About Heart Failure

Heart failure is a debilitating syndrome affecting over 5 million people in the United States. Over 3 million patients are hospitalized each year with a primary or secondary diagnosis of heart failure in the United States. Heart failure is among the most common causes of hospitalization in patients over 65 years of age and is the leading cause of rehospitalization in Medicare beneficiaries. Despite available therapies, readmission rates for patients remain high within one year of hospital discharge and mortality rates exceed 50% over the five-year period following a diagnosis of heart failure. The prevalence of heart failure is increasing with the aging population and the increased likelihood of survival following acute myocardial infarction. The limited effectiveness of current therapies points to the urgent need for next-generation therapeutics.

About Cytokinetics

Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Cytokinetics is developing tirasemtiv, a fast skeletal muscle activator, as a potential treatment for amyotrophic lateral sclerosis (ALS). Tirasemtiv has been granted orphan drug designation and fast track status by the U.S. Food and Drug Administration and orphan medicinal product designation by the European Medicines Agency for the potential treatment of ALS. Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a cardiac muscle activator, for the potential treatment of heart failure. Cytokinetics is collaborating with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy. Amgen holds an exclusive license worldwide to develop and commercialize omecamtiv mecarbil and Astellas holds an exclusive license worldwide to develop and commercialize CK-2127107. Both licenses are subject to Cytokinetics’ specified development and commercialization participation rights. All of these drug candidates have arisen from Cytokinetics’ muscle biology focused research activities and are directed towards the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. Additional information about Cytokinetics can be obtained at http://www.cytokinetics.com/.

Forward-Looking Statements

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the Act). Cytokinetics disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Acts Safe Harbor for forward-looking statements. Examples of such statements include, but are not limited to, statements relating to Cytokinetics and its partners research and development activities, including the conduct, design, enrollment, progress and results of clinical trials, the significance and utility of preclinical data and clinical trial results, anticipated timing for the availability of results from COSMIC-HF, the initiation of a potential Phase III registration program for omecamtiv mecarbil; the properties and potential ben

Related Mechanic Press Releases

Latest Auto Mechanic News

Miles Costello
He worked over 30 years as an auto mechanic and lovingly raised 10 children in Fremont, with his wife of over 62 years. He was a devout Catholic, member of Sacred Heart Church in Greeley, and a longtime member of the Knights of Columbus. Bud loved …
Read more on Fremont Tribune

Tyler man has execution date set
A Tyler man who was sentenced to die for the 2001 robbery and murder of a 75-year-old auto mechanic has had an execution date set in June. Smith County District Attorney Matt Bingham said State 114th District Judge Christy Kennedy set the execution …
Read more on Tyler Morning Telegraph

KETV Chronicle: Better Business Bureau & 7 Can Help
PLUMBING, auto repair, HOME BUILDERS. IS IT BECAUSE THEY ARE SERVICE ORIENTED THAT THEY ARE MORE COMMON? A LOT OF THESE HIRING INQUIRING INDUSTRIES REQUIRE BIG EXPENDITURES. IF YOU ARE GOING TO REMODEL …
Read more on KETV Omaha

Rise in Global Production of PCBs Drives the Surface Mount Technology Equipment Market, According to a New Report by Global Industry Analysts, Inc.

San Jose, California (PRWEB) February 10, 2015

Follow us on LinkedIn The global market for Surface Mount Technology (SMT) equipment is driven by the telecommunications, computing and consumer appliances sectors, all of which are prolific users of Printed Circuit Boards (PCBs). PCBs are vital components of the omnipresent IC chip technology present in virtually all modern electronic devices. Earlier, components were mounted onto a PCB board using the through-hole technology either manually or by using automated insertion mount machines. However, the miniaturization trend led to significant board size reductions, making integration of electronic components onto a board a daunting task. SMT today plays a vital role in the PCB assembling process by enabling mounting of active and passive electronic components directly onto the surface of PCBs. Over the years, SMT equipment has contributed significantly towards simplifying PCB assembly operations, and enabling mass production of electronic devices.

Future growth in the market is forecast to come from emerging opportunities in automotive electronics, medical device electronics, aerospace, defense and military electronics. Adoption of advanced SMT equipment will be driven by the shifting focus of end-use markets from defect detection to defect prevention. The scenario is also creating lucrative opportunities for sophisticated SMT placement and inspection equipment. Demand for SMT inspection equipment is driven by the need to reduce resource wastages stemming from manufacturing defects, improve manufacturing processes, reduce associated costs, increase yield and enhance margins. Rising demand for light emitting diodes (LED) technology is also fuelling demand for SMT equipment. Encouraged by the growing popularity of LEDs, SMT equipment manufacturers are planning production capacity additions to accommodate the increasing demand from commercial and consumer electronics sectors.

As stated by the new market research report on Surface Mount Technology (SMT) Equipment, Asia-Pacific represents the single largest market worldwide. The region is forecast to emerge as the fastest growing market with a CAGR of 7.9% over the analysis period led by robust pace of industrialization, and growth in consumer and automotive electronics. SMT placement equipment represents the largest product market supported by the miniaturization trend and the resulting need for higher accuracy in the placement of semiconductor active components such as transistors and diodes, among others. In the SMT Inspection Systems market, Automatic X-Ray Inspection (AXI) Equipment and Automatic Optical Inspection (AOI) Equipment are expected to witness strong growth. AXI equipment is expected to benefit from the integration of computer tomography and intuitive programming.

Major players in the market include ASM Assembly Systems GmbH & Co. KG, Assembl

Do you really want to become a Auto technician or mechanic?

After more than 35 years in the auto business I give a heads up on the true nature of being in the car business as a technician.
Video Rating: 5 / 5

Info Now you can own and operate your own auto repair service with PlayWay’s Car Mechanic Simulator 2014.┬┤Car Mechanic Simulator 2014 gives you the behin…
Video Rating: 4 / 5